The transcriptomic heterogeneity and functional diversities of TAMs have recently been revealed in different cancer types of both humans[18, 28] and mice.[14, 25, 40, 41] We next sought to dissect how the implanted liver tumors would impact TAM populations in different sites and their responses to anti‐PD‐1 treatment. Here, PDCD1 is linked to cancer.